cannabigerol quinone (Aphios)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecannabigerol quinone (Aphios)
Drug Alias Namecannabigerol quinonecannabigerol hydroxyquinoneVCE-003 (Aphios)VCE-003CBG-Q +[6] 
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmerald Health Biotechnology España SLU +[2] 
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A